Stockscreener 앱 받기
5.05
5.25%
-0.28
전일 마감가:
$5.33
열려 있는:
$5.5
하루 거래량:
28,098
Relative Volume:
0.85
시가총액:
$38.16M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.96%
1개월 성능:
+27.53%
6개월 성능:
-10.30%
1년 성능:
+0.00%
1일 변동 폭
$5.05
$5.69
1주일 범위
$4.68
$5.69
52주 변동 폭
$3.4962
$50.82
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
RADX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RADX
Radiopharm Theranostics Ltd Adr
|
5.05 | 38.16M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Radiopharm Theranostics Ltd Adr Stock (RADX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-12 | 개시 | B. Riley Securities | Buy |
Radiopharm Theranostics Ltd Adr 주식(RADX)의 최신 뉴스
Radiopharm wins FDA fast track for cancer imaging agent By Investing.com - Investing.com South Africa
Radiopharm wins FDA fast track for cancer imaging agent - Investing.com
Analysts Offer Insights on NA Companies: Tempus AI, Inc. Class A (TEM) and Rapport Therapeutics, Inc. (RAPP) - The Globe and Mail
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors - GlobeNewswire Inc.
radiopharm theranostics begins patient dosing in new trial - Investing.com
radiopharm theranostics begins patient dosing in new trial By Investing.com - Investing.com India
radiopharm theranostics shares preclinical data on new cancer therapy By Investing.com - Investing.com South Africa
radiopharm theranostics shares preclinical data on new cancer therapy - Investing.com
Radiopharm secures lutetium-177 supply agreement By Investing.com - Investing.com South Africa
Radiopharm Theranostics Secures Lutetium-177 Supply Agreement with ITM - TipRanks
Radiopharm secures lutetium-177 supply agreement - Investing.com
Radiopharm advances RAD204 trial with expedited phase By Investing.com - Investing.com India
Radiopharm advances RAD204 trial with expedited phase - Investing.com
RADX: Initiating Coverage – Adding a Radioisotope to Precision Oncology - Zacks Small Cap Research
ThinkEquity initiates Radiopharm stock with Buy, $15 target By Investing.com - Investing.com India
ThinkEquity initiates Radiopharm stock with Buy, $15 target - Investing.com
Radiopharm advances brain cancer diagnosis with new trial By Investing.com - Investing.com South Africa
Radiopharm advances brain cancer diagnosis with new trial - Investing.com
Radiopharm Theranostics says new data confirms positive tumour uptake - Biotech Dispatch
Radiopharm Theranostics Engages in Key Healthcare Conferences - TipRanks
B.Riley sets $15 target on Radiopharm Theranostics stock - Investing.com India
Radiopharm Theranostics Announces Director’s Interest Change and Securities Cessation - TipRanks
Radiopharm joins B Riley Radiopharma Conference - Investing.com
Radiopharm reveals positive brain metastases trial data - Investing.com India
Top 3 Health Care Stocks You'll Regret Missing This Month - Benzinga
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
Radiopharm completes preclinical tests for cancer drug RAD 402 - Investing.com
United States shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com India
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.54% - Investing.com UK
Radiopharm Achieves Nasdaq Listing of American Depositary Shares - GlobeNewswire
Radiopharm Theranostics (ASX:RAD) Advances Cancer Trials and Expands US Presence - Kalkine Media
Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited - FinancialContent
DBDeutsche Bk Latest Stock News & Market Updates - StockTitan
Market Data Center - Barron's
U.S. STOCKS - The Wall Street Journal
Radiopharm Theranostics Ltd Adr (RADX) 재무 분석
Radiopharm Theranostics Ltd Adr (RADX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.91%
1.17%
자본화:
|
볼륨(24시간):